Advertisement
For patients with ischemic stroke with an unknown time of onset

Alteplase Good for Ischemic Stroke With Unknown Onset Time

0
Better functional outcomes with alteplase, but small increased rate of intracranial hemorrhage
For patients with episodic migraine

Fremanezumab Linked to Fewer Monthly Migraine Days

0
For episodic migraine patients, reduction in number of migraine days with monthly dosing, single dose
A shower cream and a body lotion with physiological lipids are effective in improving skin hydration in patients with dry skin

Shower Cream, Body Lotion Combo Improves Atopic Dry Skin

0
Physiological lipids in the products restore skin barrier function, hydration
For pediatric patients undergoing cardiac surgery

Early Post-Op APAP Exposure May Cut AKI Risk in Peds Cardiac Sx

0
Early acetaminophen exposure after pediatric cardiac surgery may reduce rate of acute kidney injury
Childhood cancer survivors frequently have clinical abnormalities attributable to peripheral neuropathy

Peripheral Neuropathy Common in Childhood Cancer Survivors

0
Long-term neurotoxicity was more frequently seen with cisplatin than with vinca alkaloids
A novel purchasing strategy could dramatically reduce the costs of medications for hepatitis C virus

Novel Purchasing Strategy Could Cut Medicaid Costs for HCV Meds

0
Strategy involves making deal with manufacturer for a lump-sum payment in return for 100 percent rebate
From 1999 to 2014 there was a decrease in prescription medication use overall among children and adolescents

Prescription Med Use in Children Down Overall From 1999 to 2014

0
Increases in eight medication classes, including asthma and ADHD medications, contraceptives
Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.

FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia

0
Retacrit is biosimilar to the drugs Epogen and Procrit
An intervention targeting the use of intravenous opioids may reduce opioid exposure

Practice Intervention Targeting IV Opioids May Cut Exposure

0
Reduction of 84 percent in intravenous opioid doses, and a 55 percent reduction in all parenteral opioids
Receipt of opioid-related payments from industry in 2014 was associated with increased opioid prescribing in 2015

Opioid-Related Payments Linked to Increase in Opioid Rx

0
Receipt of any opioid-related payment from industry in 2014 tied to increase in opioid claims in 2015